
|Articles|April 18, 2015
Dr. Bishoy Faltas on the Future of Bladder Cancer Therapy
Bishoy M. Faltas, medical fellow at Weill Cornell Medical College, explains how the genomic landscape of bladder cancers has an impact on possible treatments for patients.
Advertisement
Bishoy M. Faltas, medical fellow at Weill Cornell Medical College, explains how the genomic landscape of bladder cancers has an impact on possible treatments for patients.
"We obviously need to identify more biomarkers," he says, which will help researchers and physicians understand the exact genetic make up of each tumor, which can help guide treatment decisions. Clinical trials are now ongoing to help researchers get to that step.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Breyanzi in Relapsed/Refractory Marginal Zone Lymphoma
2
11 Years Living With Stage 4 Cancer Inspires Gratitude and Reflection
3
Every FDA Oncology Approval From November 2025
4
What Patients Should Know About EGFR Mutated Lung Cancer Treatment
5





